These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Fate of patients with pulmonary tuberculosis and secondary drug resistance to the major drugs]. Kost A Gruzlica; 1969 Nov; 37(11):997-1002. PubMed ID: 5368630 [No Abstract] [Full Text] [Related]
5. [Tuberculostatic test in the treatment of pulmonary tuberculosis with 1st and 2d class drugs]. Gur'ian IE; Svitneva AS; Tarasova EF Probl Tuberk; 1971; 49(12):33-6. PubMed ID: 5003602 [No Abstract] [Full Text] [Related]
6. [Clinical limits of microbial resistance to secondary antitubercular agents]. Sakurai H; Hashimoto T Saishin Igaku; 1966 Jan; 21(1):88-94. PubMed ID: 5965948 [No Abstract] [Full Text] [Related]
7. [Results of treatment of pulmonary tuberculosis in aged patients (after 6-years of observation)]. Smaga M; Cyganiewicz E; Mysakowska H Gruzlica; 1967; 35(11):1181-6. PubMed ID: 6063622 [No Abstract] [Full Text] [Related]
9. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)]. Yamaguchi S Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475 [No Abstract] [Full Text] [Related]
10. [Early and late results of treatment of patients with tuberculosis shedding mycobacteria with primary resistance to basic antituberculous drugs]. Dubrawska H; Gryziecka T; Maceluch-Wojtkowa M; Orzechowska W Wiad Lek; 1968 Jan; 21(2):77-80. PubMed ID: 5671874 [No Abstract] [Full Text] [Related]
11. [Results of 30 year follow-ups of pulmonary tuberculosis patients contingent with isolated drug resistant or sensitive strains]. Zhukova MP Probl Tuberk; 1997; (5):12-5. PubMed ID: 9454239 [TBL] [Abstract][Full Text] [Related]
12. [Observations on antituberculous drug resistance among pulmonary tuberculosis patients at the national sanatoria in Kyushu district. 4. The primary and the secondary antituberculous agents]. Yamaguchi S Iryo; 1968 Oct; 22(10):1120-4. PubMed ID: 5710123 [No Abstract] [Full Text] [Related]
13. Studies on the open negative syndrome resulting from chemotherapy with secondary anti-tuberculosis agents. Kimura Y Jpn J Tuberc; 1966 Dec; 13():Suppl:71-6. PubMed ID: 5298482 [No Abstract] [Full Text] [Related]
14. [Combined use of various secondary antitubercular agents]. Kekkaku; 1968 Mar; 43(3):45-7. PubMed ID: 4877917 [No Abstract] [Full Text] [Related]
15. [Comparison of late results of treatment of patients operated on for pulmonary tuberculosis and those refusing surgery]. Jaworski J Gruzlica; 1971 Sep; 39(9):905-12. PubMed ID: 5111367 [No Abstract] [Full Text] [Related]
16. [Anatomoclinical study of the incidence of some factors of chronicization of treated pulmonary tuberculosis]. Diaconiţă G; Ionescu J; Luţescu L Ftiziologia; 1973; 22(5):485-92. PubMed ID: 4751364 [No Abstract] [Full Text] [Related]
17. [Results of the treatment in patients with pulmonary tuberculosis excreting bacilli in primary resistance to antitubercular drugs]. Hornung S; Polończyk M Gruzlica; 1965 Oct; 33(10):886-9. PubMed ID: 5881604 [No Abstract] [Full Text] [Related]
18. [Effect of the inhalation of tuberculostatic aerosols on the dynamics of bacterial excretion in pulmonary tuberculosis patients]. Protsiuk RG Probl Tuberk; 1983 May; (5):38-42. PubMed ID: 6408637 [No Abstract] [Full Text] [Related]
20. [Significance of the mycobacterial resistance to antitubercular agents in the therapeutic results of treatments of polyresistant patients]. Jancik E; Novák M; Feitová S; Jan ciková M; Tousek J Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):325-8. PubMed ID: 5897860 [No Abstract] [Full Text] [Related] [Next] [New Search]